FDA-approved
Digestive & weight
Teduglutide
Evidence
FDA approved
Class
GLP-2 receptor agonist
KEY TAKEAWAY
Teduglutide is a modified version of GLP-2, a gut hormone that supports growth of the intestinal lining. It is sold as Gattex. The FDA approved teduglutide (Gattex) in 2012 for adults with short bowel syndrome, and later for children.
Written by the Veylo editorial team · Updated
November 2026
What it is
GLP-2 receptor agonist
Approved for
Short bowel syndrome that depends on intravenous nutrition
Key fact
The FDA approved teduglutide (Gattex) in 2012 for adults with short bowel syndrome, and later for children.
Route
Daily subcutaneous injection
Evidence strength
FDA approved
Teduglutide is a modified version of GLP-2, a gut hormone that supports growth of the intestinal lining. It is sold as Gattex.
It activates GLP-2 receptors, which increases absorption of fluid and nutrients by helping the intestinal lining grow.
The FDA approved teduglutide (Gattex) in 2012 for adults with short bowel syndrome, and later for children.
Short bowel syndrome that depends on intravenous nutrition.
Abdominal pain, swelling and nausea are common. Because it promotes growth of the gut lining, it can enlarge polyps, so colonoscopy monitoring is needed.
U.S. FDA prescribing information for Teduglutide. DailyMed, National Library of Medicine.
Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.